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The receptor for bombesin and the related peptide, gastrin-releasing peptide (GRP) has been induced in frog oocytes 
by injection of polyA+ RNA from rat brain. The primed oocytes responded to peptides of the bombesin family (GRP, 
neuromedin C of bombesin) by showing dose-dependent oscillations in membrane currents as recorded by the voltage- 
clamp method. The induced membrane changes were suppressed when oocytes were pretreated with a bombesin-receptor 
antagonist. 
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1. INTRODUCTION 
The amphibian tetradecapeptide bombesin and 
its mammalian homologue, the twenty-seven 
residue gastrin-releasing peptide (GRP) [ 1,2], exert 
a diverse range of biological effects. These include 
roles in thermoregulation, blood-sugar stasis and 
sympathetic outflow, each mediated via the central 
nervous system [3], while in the gastrointestinal 
tract GRP potentiates the release of 
gastrointestinal hormones [4,5]. Further, in 
pulmonary neuroendocrine cells and in small cell 
carcinomas in vivo, GRP has been reported to 
function as an autocrine growth factor [6-81. 
Putative receptors for bombesin and GRP have 
been demonstrated in various tissues and organs 
including brain [9-l 11. In Swiss 3T3 cells the 
receptor for peptides of the bombesin family ap- 
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pears to be linked to the inositol triphosphate se- 
cond messenger system which in turn mediates the 
intracellular mobilization of Ca2+ [ 121. 
Recently we ‘have demonstrated the expression 
of receptors for certain neuropeptides in voltage- 
clamped Xenopus oocytes primed with mRNA 
from receptor-containing tissues [ 13,141. Positive 
responses were observed for those receptors known 
to respond to ligand activation in vivo by trigger- 
ing inositol phospholipid breakdown leading to 
Ca2+ release from intracellular stores. Apparently 
certain receptors when induced in frog oocytes are 
capable of interacting with endogenous G- 
protein(s), which probably function(s) as coupling 
(a) element(s) in the intracellular signaling pathway 
between the receptor and endogenous 
Ca2+-activated ion channels. Here we report that 
the brain receptor for peptides of the bombesin 
family represents a further example of a receptor 
that can be expressed and electrophysiologically 
identified in frog oocytes, primed in this case with 
brain mRNA. 
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2. MATERIALS AND METHQQS 
Bombesin, GRP, GRPw27, neuromedin C (GRPsz), 
[Lyssl-bombesin, N-~&yi_GRP29-27 and the bombesin 
receptor antagonist ID-Pha’*,~“]bombe$in were purchased 
from Bachem, Basel, and Pani&@, $& ~elcns, England. 
2.1. PolyA* RNA preparation and ooeyi@ &j&j@fl,q 
PolyA* RNA was prepared from rat brain t%nd 90 d RJ$A 
solution (0.5 pg/ml In 10 mM Tris-HC1, pH 7.5, 100 my 
NaCI) injected into stage V mfles of Xenopus laevis as 
reported previously [131. Oocyt~s were kept irr ,!$&& g&&p 
at 20°C for l-4 days. For further purifie&& p~$yA+ RNA 
was ize-fractionated on a NaDodS% sucrose-den&y gradient 
as described earlier [14]. The c~jw ff;aFtinns y@~g prc- 
cipitated twice with ethanol, taken up in 10 pj d j$@ gupcj 50 QL 
aliquots used for injection into oocytes [14], 
2.2. Voltage clamping of oocytes 
Whole-cell current meslsuremw@ ere performed atroom 
temperature with a conventional t nm-m&rM@rode voltage 
clamp in Ringer’s solution [151, 39ka men&yane potential was 
adjusted to- 60 mV and voltage clampaQ, The membrane cur- 
rent signal was filtered with a corner freqw_w of 0.3 kHz. 
Ligands were perfused, at the concentrgfjons ja&~rrf& in 
Ringer solution or applied dir&y &J &he m+cy’a bath w&R w 
syringe. 
3. RESULTS 
In order to establish if the receptor for the 
bombesin-related family of peptides can be ex- 
pressed and functionally sletected by the voltage- 
clamp method, polyA* RNA was prepar,ed from 
rat brain and injected into Xenopus luevis oocytes. 
When exposed ts bombesin in the incubation bath, 
the injected oocytes responded by showing oscilla- 
tions in membrane currents, indicating that expres- 
sion of the bombesin receptor can be functionally 
detected in frog oocytes (fig.1). The bombesin- 
evoked response was not observed with oocytes 
sham-injected with buffer. 
Fig.1 shows that oocytes primed with rat brain 
polyA+ RNA also express the receptors for 
serotonin and thyiotropin-releasing hormone 
(TRH) [ 131 as indicated by responses to the respec- 
tive ligands when added to the incubation bath. 
Additionally, small but significant signals were ob- 
tained in response to substance P and histamine, 
suggesting the presence of induced receptors for 
these ligands in the injected oocytes (not shown). 
In general the observed oscillating current 
response for serotonin was at least a magnitude of 
order larger than those evoked either by bombesin 
110 
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Fig.!. Whole ~~11 current traces of X. laevis oocytes. After 
microinjection Qf 50 nl qf rat brain polyA: RNA (0.5 pg/& 
into oocytes the latter were voltage clamped at -60 mV, 
perfused with frog Ringer’s solution and exposed to 1 PM 
bembesin (A), 0.1 pM serotonin (B) or 1OpM TRH (C). The 
bars denote the duration of ligand application. Time and 
current scales are given by the rectangle: horizontal, 1 min; 
vertical, 10 nA. 
or TRH which in turn were significantly greater 
than those for substance P and histamine. This 
may reflect a significantly higher abundance of the 
mRNA encoding the serotonin receptor compared 
to that for the bombesin, TRH, substance P or 
histamine receptors. Furthermore, oocytes when 
exposed to serotonin exhibited a bi-phasic response 
with an initial rapid and transient depolarizing cur- 
rent, follqwed by a prolonged fluctuating current 
of smaller amplitude. This initial rapid depolariz- 
ing current is significantly reduced or even absent 
in the case of ‘the bombesin- and TRH-evoked 
response. 
Fig.2 shows membrane current responses of frog 
oocytes evoked by peptides of the bombesin family 
(table 1). Oocytes previously injected with rat 
brain polyA+ RNA responded to bombesin (A), 
[Lys3]bombesin (B), GRP (C), GRP14-27 (D), 
GRPI~._~~ (neuromedin C; E) and N-[cu-lacetyl 
GRPzo_z7 (F), respectively. In most experiments 
maximal response was observed with bombesin; N- 
terminally truncated GRP20_27 was as active as full 
length GRP suggesting that the C-terminus of the 
mammalian hormone GRP is essential for its in- 
teraction with the brain receptor. 
When brain polyA+ RNA was size-fractionated 
on SDS-sucrose density gradients as reported 
recently [13,14] and aliquots of individual frac- 
tions were injected into oocytes, the major activity 
peak travelled at or slightly ahead of the position 
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Fig.2. Membrane current responses of a brain polyA+ RNA 
primed X. luevis oocyte evoked by peptides of the bombesin 
family. A voltage-clamped oocyte previously injected with rat 
brain polyA+ RNA was subsequently treated with 0.1 pM 
bombesin (A), 0.1 gM [Lys’Jbombesin (B), 1 FM GRP (C); 
1 gM GRPw27 (D), 1 pM GRPK-~~ (neuromedin C) (E), and 
1 PM N-cu-acetyl-GRP2+27 (F) as indicated by the bars. The 
oocyte was perfused 15 min with frog Ringer’s solution prior to 
peptide applications. 
of the 18 S rRNA suggesting that the mRNA en- 
coding the bombesin receptor is greater than 2 kb 
in length. 
To determine if the bombesin receptor func- 
tionally expressed in frog oocytes shows similar 
pharmacological properties to the brain receptor, a 
bombesin-receptor antagonist [D-Phe12,Leu’4]- 
bombesin was applied together with either the 
ligand bombesin or N-a-acetyl GRPzo-~~. Fig.3 
shows that the antagonist suppressed the bombesin 
and N-a-acetyl GRPzo-2,-specific response in a 
dose-dependent manner. 
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Fig.?. Effect of a bombesin-receptor antagonist, [D- 
Pher3,Leu’4]bombesin- and N-cu-acetyl-GRPzc-zr-evoked whole 
cell current responses. Membrane current responses of voltage- 
clamped oocytes to challenge with 0.1 ,uM bombesin (A) or 
I pM A&-acetyl-GRP2+27 (B) in the presence and absence of 
a bombesin receptor antagonist. In A the antagonist was used 
at 100-fold (left) and 25fold (middle) molar excess; in B a 
5-fold (left) and IO-fold (middle) molar excess was used. 
Responses in the absence of antagonist are shown on the right. 
Following each treatment oocytes were perfused with frog 
Ringer’s solution for 15 min. The time and current scale is given 
by rectangles: horizontal, 1 min; vertical, 10 nA. 
4. DISCUSSION 
The data presented here show that polyA+ RNA 
isolated from rat brain encodes a receptor that 
recognizes peptides of the bombesin family and 
which can be functionally expressed and elec- 
trophysiologically recorded in oocytes from X. 
laevis. The expressed receptor shows similar phar- 
macological properties to that from the brain, in- 
sofar as the electrophysiological response can be 
triggered by bombesin and GRP agonists while a 
bombesin-receptor antagonist blocks this effect. 
Bombesin and GRP are known to induce inositol 
triphosphate-mediated Ca2+ release from in- 
111 
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tracellular stores [ 11,12,16] probably by activating 
a phospholipase C which hydrolyzes phosphatidyl- 
inositol-4,Sbisphosphate to yield 1,2_diacylglycer- 
01, and inositol-1,4,5trisphosphate second 
messengers. This signal transduction mechanism 
can be mimicked in frog oocytes leading ultimately 
to Ca*+-mediated ion-channel opening probably of 
the chloride type [ 171. The fact that a number of 
other receptors can be expressed similarly in the 
frog oocyte [13-15,18-241 suggests that certain 
transmitter and peptide hormone signal transduc- 
tion pathways proceed via a generalized and con- 
served mechanism. 
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